Hypoxia as a target for combined modality treatments

Author： Wouters B.G.   Weppler S.A.   Koritzinsky M.   Landuyt W.   Nuyts S.   Theys J.   Chiu R.K.   Lambin P.  

Publisher： Elsevier

ISSN： 0959-8049

Source： European Journal of Cancer, Vol.38, Iss.2, 2002-01, pp. : 240-257

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Topoisomerase I as a target of erlotinib and gefitinib: Efficacy of combined treatments with camptothecin

By      

International Journal of Oncology, Vol. 44, Iss. 3, 2014-01 ,pp. : 934-942

Spandidos Publications

Access to resources Recommend Favorite

Indications for and Results of Combined Modality Treatment of Colorectal Cancer

By Gunderson Leonard L.  

Acta Oncologica, Vol. 38, Iss. 1, 1999-02 ,pp. : 7-21

Informa Healthcare

Access to resources Recommend Favorite

Interview: Combined-modality therapy in gastrointestinal cancers

By Thomas Charles Richard  

Colorectal Cancer, Vol. 2, Iss. 1, 2013-02 ,pp. : 27-30

Future Medicine

Access to resources Recommend Favorite

Prostatic leiomyosarcoma: the case for combined modality therapy

By El-Sharkawi Salah   Vaughton Keith  

Sarcoma, Vol. 1, Iss. 1, 1997-03 ,pp. : 59-60

Informa Healthcare

Access to resources Recommend Favorite

Antiangiogenesis and Radiotherapy: What Is the Role of Combined Modality Treatment?

By  

Current Medicinal Chemistry - Anti-Cancer Agents, Vol. 3, Iss. 5, 2003-01 ,pp. : 375-382

Bentham Science Publishers

Access to resources Recommend Favorite